BACKGROUND & OBJECTIVES: Limited data are available on malignancies in human immunodeficiency virus (HIV)-infected patients from India. We undertook this study to assess the frequency and spectrum of malignancies in HIV-infected adult patients during the first eight years of highly active antiretroviral therapy (HAART) rollout under the National ART Programme at a tertiary care centre in New Delhi, India. METHODS: Retrospective analysis of records of patients registered at the ART clinic between May 2005 and December 2013 was done. RESULTS: The study included 2598 HIV-infected adult patients with 8315 person-years of follow up. Malignancies were diagnosed in 26 patients with a rate of 3.1 (IQR 2.1-4.5) cases per 1000 person-years. The median age for those diagnosed with malignancy was 45 (IQR 36-54) yr, which was significantly (P<0.01) higher compared with those not developing malignancies 35 (IQR 30-40) yr. The median baseline CD4+ T-cell count in patients with malignancy was 135 (IQR 68-269) cells/µl compared to 164 (IQR 86-243) cells/µl in those without malignancies. AIDS-defining cancers (ADCs) were seen in 19 (73%) patients, while non-AIDS-defining cancers (NADCs) were observed in seven (27%) patients. Malignancies diagnosed included non-Hodgkin's lymphoma (16), carcinoma cervix (3), Hodgkin's lymphoma (2), carcinoma lung (2), hepatocellular carcinoma (1), and urinary bladder carcinoma (1). One patient had primary central nervous system lymphoma. There was no case of Kaposi's sarcoma. INTERPRETATION & CONCLUSIONS: Malignancies in HIV-infected adult patients were infrequent in patients attending the clinic. Majority of the patients presented with advanced immunosuppression and the ADCs, NHL in particular, were the commonest malignancies.
BACKGROUND & OBJECTIVES: Limited data are available on malignancies in human immunodeficiency virus (HIV)-infectedpatients from India. We undertook this study to assess the frequency and spectrum of malignancies in HIV-infected adult patients during the first eight years of highly active antiretroviral therapy (HAART) rollout under the National ART Programme at a tertiary care centre in New Delhi, India. METHODS: Retrospective analysis of records of patients registered at the ART clinic between May 2005 and December 2013 was done. RESULTS: The study included 2598 HIV-infected adultpatients with 8315 person-years of follow up. Malignancies were diagnosed in 26 patients with a rate of 3.1 (IQR 2.1-4.5) cases per 1000 person-years. The median age for those diagnosed with malignancy was 45 (IQR 36-54) yr, which was significantly (P<0.01) higher compared with those not developing malignancies 35 (IQR 30-40) yr. The median baseline CD4+ T-cell count in patients with malignancy was 135 (IQR 68-269) cells/µl compared to 164 (IQR 86-243) cells/µl in those without malignancies. AIDS-defining cancers (ADCs) were seen in 19 (73%) patients, while non-AIDS-defining cancers (NADCs) were observed in seven (27%) patients. Malignancies diagnosed included non-Hodgkin's lymphoma (16), carcinoma cervix (3), Hodgkin's lymphoma (2), carcinoma lung (2), hepatocellular carcinoma (1), and urinary bladder carcinoma (1). One patient had primary central nervous system lymphoma. There was no case of Kaposi's sarcoma. INTERPRETATION & CONCLUSIONS:Malignancies in HIV-infected adult patients were infrequent in patients attending the clinic. Majority of the patients presented with advanced immunosuppression and the ADCs, NHL in particular, were the commonest malignancies.
Authors: Nancy Crum-Cianflone; Katherine Huppler Hullsiek; Vincent Marconi; Amy Weintrob; Anuradha Ganesan; R Vincent Barthel; Susan Fraser; Brian K Agan; Scott Wegner Journal: AIDS Date: 2009-01-02 Impact factor: 4.177
Authors: Meredith S Shiels; Ruth M Pfeiffer; Mitchell H Gail; H Irene Hall; Jianmin Li; Anil K Chaturvedi; Kishor Bhatia; Thomas S Uldrick; Robert Yarchoan; James J Goedert; Eric A Engels Journal: J Natl Cancer Inst Date: 2011-04-11 Impact factor: 13.506
Authors: Uday A Phatak; Ravindra Joshi; Dinesh K Badakh; Vikas S Gosavi; Jayanti U Phatak; Rakhi V Jagdale Journal: J Assoc Physicians India Date: 2010-03
Authors: K K Venkatesh; S Saghayam; B Devaleenal; S Poongulali; T P Flanigan; K H Mayer; N Kumarasamy Journal: Indian J Cancer Date: 2012 Jan-Mar Impact factor: 1.224
Authors: Kathy Petoumenos; Eugenie Hui; Nagalingeswaran Kumarasamy; Stephen J Kerr; Jun Yong Choi; Yi-Ming A Chen; Tuti Merati; Fujie Zhang; Poh-Lian Lim; Somnuek Sungkanuparph; Sanjay Pujari; Sasheela Ponnampalavanar; Rosanna Ditangco; Christopher Kc Lee; Andrew Grulich; Matthew G Law Journal: J Int AIDS Soc Date: 2010-12-10 Impact factor: 5.396
Authors: Sheela V Godbole; Karabi Nandy; Mansi Gauniyal; Pallavi Nalawade; Suvarna Sane; Shravani Koyande; Joy Toyama; Asha Hegde; Phil Virgo; Kishor Bhatia; Ramesh S Paranjape; Arun R Risbud; Sam M Mbulaiteye; Ronald T Mitsuyasu Journal: Medicine (Baltimore) Date: 2016-09 Impact factor: 1.889
Authors: Sanjeev Sinha; Ashish Agarwal; Kartik Gupta; Dibyakanti Mandal; Mitul Jain; Roger Detels; Karabi Nandy; Michelle A DeVos; S K Sharma; N Manoharan; P K Julka; G K Rath; Richard F Ambinder; Ronald T Mitsuyasu Journal: Curr HIV Res Date: 2018 Impact factor: 1.581